Regeneron Pharmaceuticals (Nasdaq: REGN) today announced that the European Commission (EC) has granted conditional marketing ...

The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining ...

Belgium’s General Association of the Pharma Industry, known as pharma.de, has emphasized the importance of intellectual ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

Comac Medical, a full-service contract research organization (CRO) based in Bulgaria, has announced major leadership changes ...

A new category of diabetes, known as type 5 diabetes, has been officially recognized by the International Diabetes Federation ...

In one of the largest all-private licensing deals so far this year, worth around 500 million euros ($569 million), ...

Merck & Co has announced results from the Phase III KEYNOTE-689 trial of Keytruda (pembrolizumab) as a perioperative ...

After reported discussions since February, German pharma and sciences company Merck KGaA (MRK: DE) has confirmed its ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) late Friday announced it has granted a conditional ...

US pharma major Pfizer (NYSE: PFE) reported new Phase III data over the weekend showing that its investigational PD-1 ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) has shared new findings for TAR-200, an intravesical gemcitabine releasing ...